Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Apo-Diltiazem CD
Diltiazem hydrochloride 120.12mg
Modified release capsule
Apotex NZ Limited
Apotex Inc, Ontario, Canada

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Apo-Diltiazem CD
Diltiazem hydrochloride 180.1mg
Modified release capsule
Apotex NZ Limited
Apotex Inc, Ontario, Canada

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Apo-Diltiazem CD
Diltiazem hydrochloride 240.1mg
Modified release capsule
Apotex NZ Limited
Apotex Inc, Ontario, Canada

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Apo-Diltiazem CD
Diltiazem hydrochloride 300mg
Modified release capsule
Apotex NZ Limited
Apotex Inc, Ontario, Canada

Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:

Spiriva Respimat
Tiotropium bromide monohydrate 3.125mcg equivalent to Tiotropium 2.5mcg/dose
Solution for inhalation
Boehringer Ingelheim (NZ) Limited
Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim am Rhein, Germany

Dated this 23rd day of April 2015.

SARAH READER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).